Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: A critical review and update

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 2, 2010, Pages 118-122

  Singh, Sonal ^a   Loke, Yoon K ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Inhaled corticosteroids; Pneumonia

Indexed keywords

CORTICOSTEROID;

CHRONIC DRUG ADMINISTRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; META ANALYSIS; MORTALITY; PNEUMONIA; REVIEW; SYSTEMATIC REVIEW;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TIME FACTORS;

EID: 76449121443     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328334c085     Document Type: Review

References (17)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2008. http:// www.goldcopd.org. (Accessed 26 October 2009)
2. Calverley PMA, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775-789.
3. Crim C, Calverley PM, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009; 34:641-647.
4. Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med 2009; 169:219-229.
5. Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007; 176:62-166.
6. GlaxoSmithKline. Assessment of Incidence of Pneumonia among COPD patients with or without exposure to inhaled corticosteroids in General Practice Research Database. http://www.gsk-clinicalstudyregister.com/ files/pdf/24060.pdf. (Accessed 26 October 2009)
7. GlaxoSmithKline. Assessment of incidence of pneumonia among COPD patients on seretide or inhaled corticosteroids in UK primary care. http://www.gsk- clinicalstudyregister.com/files/pdf/24056.pdf. (Accessed 26 October 2009)
8. Sin D, Tashkin D, Xuekui Zhang X, et al. Budesonide and the risk of pneumonia: a meta-analysis of individual patient data. Lancet 2009; 374:712-719.
9. Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300:2407-2416.
10. Loke YK, Singh S. Inhaled corticosteroids in patients with chronic obstructive pulmonary disease. JAMA 2009; 301:1432-1434.
11. Sobieraj DM, White CM, Coleman CI. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther 2008; 30:1416-1425.
12. Nannini LJ, Cates CJ, Lasserson TJ, Poole P. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007:CD006829.
13. Rodrigo GJ, Castro-Rodriguez JA, Plaza V. Safety and efficacy of combined long-acting {beta}-agonists and inhaled corticosteroids vs long-acting {beta}- agonists monotherapy for stable COPD: a systematic review. Chest 2009; 136:1029-1038.
14. Vestbo J, Sørensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353:1819-1823.
15. Rennard SI, Tashkin DP, McElhattan J, et al. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. Drugs 2009; 69:549-565.
16. Pauwels RA, Löfdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999; 340:1948-1953.
17. Joo MJ, Au DH, Fitzgibbon ML, et al. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respir Med 2009 [Epub ahead of print]. doi:10.1016/j.rmed.2009.10.002.